Introduction {#s1}
============

The major role of vitamin D in the human body is commonly thought to be related to calcium metabolism and bone structure. However, scientific evidence clearly indicates that the biological importance of this vitamin greatly exceeds these aspects. The 25-hydroxyvitamin D \[25(OH)D\] is the main circulating metabolite of vitamin D, and is considered to be an indicator of vitamin D status in the human body [@pone.0099316-Giovannucci1]. Low 25(OH)D is considered to play an important role in the development of cardiovascular diseases, metabolic syndrome, type 2 diabetes mellitus, inflammatory and immune abnormalities, and sleep disorders [@pone.0099316-Norman1]--[@pone.0099316-Gominak1]. To the best of our knowledge, there is no report concerning the relationship between 25(OH)D and nocturnal enuresis (NE) in the English literature.

NE is defined as nighttime bedwetting (≥2times per week) in children five years of age or older [@pone.0099316-Neveus1] and is the most common voiding problem in pediatric population. The prevalence of NE in children worldwide has been reported to range from 1.4% to 28% depending on the definition of enuresis, children\'s ages, and cultural differences [@pone.0099316-Ozden1]--[@pone.0099316-Gumus1]. Due to its high prevalence, NE has remained a focus of extensive scientific research over the past few decades. The etiology of NE has been widely debated but currently remains unclear. The commonly established causes of NE are arousal dysfunction and nocturnal polyuria [@pone.0099316-Butler1]--[@pone.0099316-Butler2]. Arousal dysfunction is related to sleep disorders [@pone.0099316-Roehrs1]. Anatomic evidence and clinical studies suggest that vitamin D may be involved in sleep regulation [@pone.0099316-Gominak1], [@pone.0099316-Eyles1]--[@pone.0099316-McCarty1]. Besides, vitamin D deficiency is associated with the severity of obstructive sleep apnea (OSA) [@pone.0099316-Abuzeid1]--[@pone.0099316-Russell1], and nocturnal polyuria is one of the main adverse outcomes of OSA [@pone.0099316-Umlauf1]. Moreover, vitamin D deficiency could directly lead to excessive urine production [@pone.0099316-Li1]. Therefore, we propose the hypothesis that there is some connection between NE and vitamin D.

In the present study, serum 25(OH)D concentrations were measured in five- to seven-year-old children with NE and compared with those in non-enuretic children to investigate any potential relationship between 25(OH)D and NE, and for the first time in the literature, to explore the possibility that a threshold serum 25(OH)D concentration in relation to NE exists in young children.

Subjects and Methods {#s2}
====================

Subjects {#s2a}
--------

From November 2012 to March 2013, 247 children were recruited from five kindergartens in Taizhou, Zhejiang Province, China. These children\'s ages ranged from 5 to 7 years old. 134 boys (54.3%) and 113 girls (45.7%) participated. Exclusion criteria included the following: 1) any medication or treatment related to nocturnal enuresis; 2) supplemental vitamin D intake \>400 IU/d; 3) subjects with age \<5 years old. Participation in the study was voluntary, and written informed consent was obtained from children\'s parents. This study was approved by the Ethics Committee of Shanghai Jiao Tong School of Medicine, China.

Questionnaires {#s2b}
--------------

A face-to-face interview with the parents was conducted by a trained doctor using a structured questionnaire. The information collected included the child\'s age, gender, gestational age, birth weight, maternal education, paternal education, and family income. Nighttime bedwetting and its severity were also recorded. The frequencies of bedwetting were graded as "occasionally" (0--1 times per week), "frequently" (2--4 times per week), and "almost always" (5--7 times per week). In this study, NE was defined as nighttime bedwetting (≥2times per week) in children five years of age or older [@pone.0099316-Neveus1].

Serum 25(OH)D measurement {#s2c}
-------------------------

Fasting venous blood samples from all participants were collected in the early morning. Serum was separated and stored in lightproof containers at −20°C until the samples were assayed for vitamin D metabolites. We used the sensitive liquid chromatographytandem mass spectrometry (LC-MS/MS) analytical method to detect serum 25(OH)D, as reported by van den Ouweland JM et al. [@pone.0099316-vandenOuweland1]. The serum samples (100 µl) were deproteinised and precipitated using methanol, acetonitrile, zinc sulfate, and internal standards that included deuterated 25(OH)D~2~ and 25(OH)D~3~ (Sigma USA). Chromatographic separations were achieved on an Agilent Poroshell 120 EC-C18(50×2.1 mm, 2.7 µm) column with a gradient of water (containing 0.1% formic acid) and methanol as the mobile phase at a flow rate of 0.5 mL/min. Multiple reaction monitoring (MRM) of the analytes was performed under electrospray ionization (ESI) in the positive mode at m/z 401.3→383.2 and 401.3→159.1 for 25(OH)D~3~, m/z 413.3→395.3 and 413.3→355.2 for 25(OH)D~2~, and m/z 404.3→386.3 and 416.4.3→398.3 for d~3~-25(OH)D~3~ and d~3~-25(OH)D~2~, respectively. Low 25(OH)D was defined as serum 25(OH)D concentrations \<20 ng/ml [@pone.0099316-Holick1]--[@pone.0099316-Saintonge1].

Statistical analyses {#s2d}
--------------------

Serum 25(OH)D concentrations analyzed in our study were normally distributed. We first performed a univariate analysis to examine group differences in NE ([Table 1](#pone-0099316-t001){ref-type="table"}) and then used multiple linear regression to estimate the independent relationship between 25(OH)D and NE after adjusting for potential confounders ([Table 2](#pone-0099316-t002){ref-type="table"}). Next, we constructed a generalized additive model to explore the relationship between 25(OH)D and NE via a smoothing plot ([Figure 1](#pone-0099316-g001){ref-type="fig"}). We further applied a two-piecewise linear regression model to examine the threshold effect of 25(OH)D on NE according to the smoothing plot ([Table 3](#pone-0099316-t003){ref-type="table"}). The inflection of 25(OH)D concentrations (i.e., the point at which the relationship between 25(OH)D and NE began to change shape and become prominent) was determined using a trial method. This trial method involved moving the trial inflection point along a pre-defined interval and detecting the inflection point that produced the maximum model likelihood. Finally, analysis of variance was used to examine the effect of 25(OH)D on the frequency of bedwetting ([Figure 2](#pone-0099316-g002){ref-type="fig"}). All analyses were performed using Empower(R) (version 2.13.9, X&Y solutions, Inc., Boston, MA) and R (version 2.15.3, Robert Gentleman and Ross Ihaka, Auckland, New Zealand).

![The Relationship between 25(OH)D and nocturnal enuresis.\
A nonlinear relationship between serum 25(OH)D concentrations and nocturnal enuresis was observed after adjusting for gender, age, gestational age, birth weight, maternal education, paternal education, and family income. A threshold for 25(OH)D of 19 ng/ml existed for nocturnal enuresis. 25(OH)D, 25-hydroxyvitamin D.](pone.0099316.g001){#pone-0099316-g001}

![The effect of 25(OH)D on the frequency of bedwetting.\
Serum 25(OH)D concentrations (mean ± SD): 5--7 times/week: 18.3±4.8(ng/ml); 2--4 times/week: 20.9±4.1(ng/ml); 0--1 times/week: 23.6±6.4 (ng/ml). Compared to the 5--7 times/week and 2--4 times/week groups, the concentrations of 25(OH)D in the 0--1 times/week group were much higher (P\<0.05). 25(OH)D, 25-hydroxyvitamin D.](pone.0099316.g002){#pone-0099316-g002}

10.1371/journal.pone.0099316.t001

###### Effects of risk factors on nocturnal enuresis (n = 247).[\*](#nt102){ref-type="table-fn"}

![](pone.0099316.t001){#pone-0099316-t001-1}

                                               Nocturnal Enuresis  
  ------------------------------------ ------ -------------------- --------
  **25(OH)D dichotomous**                                          
  \<P50(22.2 ng/ml)                      50           17.0          \<0.05
  ≥P50(22.2 ng/ml)                       50           6.8          
  **Low 25(OH)D (\<20 ng/ml)**                                     
  Yes                                   29.9          17.5          \<0.05
  No                                    70.1          7.3          
  **Gender**                                                       
  male                                  54.3          16.0          \>0.05
  female                                45.7          8.3          
  **Age**                                                          
  5 years                               33.2          15.4          \>0.05
  6 years                               47.0          12.2         
  7 years                               19.8          8.6          
  **Gestational age**                                              
  Preterm infant                        8.9           20.0          \>0.05
  Term infant                           91.1          11.6         
  **Low birth weight**                                             
  No                                    98.0          13.5          \>0.05
  Yes                                   2.0            0           
  **Maternal education**                                           
  Primary school                        23.2          17.9          \>0.05
  Middle school                         58.5          13.5         
  High school                           13.7          6.5          
  Bachelor degree or higher             4.6            0           
  **Paternal education**                                           
  Primary school                        14.1          19.2          \>0.05
  Middle school                         64.3          13.6         
  High school                           18.3          7.9          
  Bachelor degree or higher             3.3            0           
  **Family incomes (Yuan/m/person)**                               
  ≤1000                                 21.2          28.6          \>0.05
  1000--2000                            29.1          7.6          
  2000--5000                            22.2          14.8         
  ≥5000                                 27.5          7.7          

25(OH)D, 25-hydroxyvitamin D.

**\***Determined by univariate analysis.

10.1371/journal.pone.0099316.t002

###### Adjusted effect of 25(OH)D on nocturnal enuresis.

![](pone.0099316.t002){#pone-0099316-t002-2}

                                   Nocturnal Enuresis                    
  ------------- -------------------------------------------------------- --------------------------------------------------------
  **25(OH)D**    0.94 (0.87, 1.0)\>0.05[†](#nt106){ref-type="table-fn"}    0.9 (0.8, 1.0)\<0.05[†](#nt106){ref-type="table-fn"}
  **25(OH)D**                                                            
  \<20(ng/ml)                             1.0                                                      1.0
  ≥20 (ng/ml)    0.52 (0.21, 1.3)\<0.05[‡](#nt107){ref-type="table-fn"}   0.31 (0.092,1.0)\<0.05[‡](#nt107){ref-type="table-fn"}

β, regression coefficient; 25(OH)D, 25-hydroxyvitamin D.

**\***Unadjusted and analyzed by using liner regression.

Adjusted for gender, age, gestational age, birth weight, maternal education, paternal education, and family income by using multiple linear regression.

Unadjusted β, 0.94; adjusted β, 0.9.

Unadjusted OR, 0.52; adjusted OR, 0.31.

10.1371/journal.pone.0099316.t003

###### Threshold effect analysis of 25(OH)D on nocturnal enuresis.[\*](#nt109){ref-type="table-fn"}

![](pone.0099316.t003){#pone-0099316-t003-3}

  Inflection point of 25(OH)D(ng/ml)     Nocturnal Enuresis
  ------------------------------------ -----------------------
  19.0                                 
  \<19.0                                1.0 (0.77, 1.3) 0.96
  ≥19.0                                 0.84 (0.7, 1.0)\<0.05

25(OH)D, 25-hydroxyvitamin D.

**\***Adjusted for gender, age, gestational age, birth weight, maternal education, paternal education, and family income by using piece-wise linear regression.

P values less than 0.05 were considered statistically significant. Moreover, because p values depend on the size of the data set, statistical inferences were assessed using estimation with confidence intervals (CI) and odds ratios (OR). If the 95% CI excluded 1, the difference between the groups was considered significant, and if the 95% CI included one, the difference was considered non-significant at p = 0.05.

Results {#s3}
=======

A total of 247 (134 males and 113 females) children aged 5 to 7 years were recruited. Of these children, 8.9% were preterm infants (gestational age\<37 weeks) and 2.0% had low birth weights (birth weight\<2500 grams). The median serum 25(OH)D concentration was 22.2 ng/ml, which is higher than the recommended concentration (20 ng/ml), and 29.9% of the children had low 25(OH)D concentrations ([Table 1](#pone-0099316-t001){ref-type="table"}).

[Table 1](#pone-0099316-t001){ref-type="table"} shows the unadjusted associations between 25(OH)D and NE. Serum 25(OH)D concentrations were associated with NE in the dichotomous analyses. The prevalence of NE decreased with the increase across the dichotomous concentrations of 25(OH)D (p\<0.05). Compared to the children with 25(OH)D concentrations above 20 ng/ml, the children with 25(OH)D concentrations below 20 ng/ml exhibited a greater risk of NE (p\<0.05). Additionally, there was no association between NE and the child\'s gender, age, gestational age, birth weight, maternal or paternal education level, or family income (p\>0.05).

[Table 2](#pone-0099316-t002){ref-type="table"} shows the adjusted association between 25(OH)D and NE. After adjusting for gender, age, gestational age, birth weight, maternal and paternal education, and family income, serum 25(OH)D concentrations were negatively associated with NE \[regression coefficient (β) = 0.9, 95% CI = 0.8, 1.0, p\<0.05\], and serum 25(OH)D greater than 20 ng/ml represented a protective factor against NE (OR = 0.31, 95% CI = 0.092, 1.0, p\<0.05).

There was a nonlinear relationship between serum 25(OH)D and NE after adjusting for confounders ([Figure 1](#pone-0099316-g001){ref-type="fig"}). When serum 25(OH)D concentrations were above the inflection point (19 ng/ml), the prevalence of NE decreased with increasing 25(OH)D concentrations (OR = 0.84, 95% CI = 0.7, 1.0, p\<0.05) ([Table 3](#pone-0099316-t003){ref-type="table"}).

[Figure 2](#pone-0099316-g002){ref-type="fig"} illustrates that higher frequencies of bedwetting were associated with lower 25(OH)D concentrations \[5--7 times/week:18.3±4.8, 2--4 times/week: 20.9±4.1, and 0--1 times/week: 23.6±6.4 (ng/ml),P\<0.05)\].

Discussion {#s4}
==========

In the present study, a statistically significant association was found between serum 25(OH)D and NE. Our data revealed that that children with lower 25(OH)D concentrations were at an increased risk of NE. We searched the medical literature for information about serum 25(OH)D concentrations in enuretic children and were unable to find any studies on this topic. Therefore, we report here, for the first time, a negative relationship between 25(OH)D and NE in 5--7 year-old children.

Vitamin D, apart from its classical effect on the regulation of calcium homeostasis and bone metabolism, has been recognized to contribute to various physiological processes. The effect of vitamin D on NE is associated with its influence on sleep disorders, OSA, and nocturnal polyuria.

NE is a common problem among children. Data have accumulated pointing to an association of sleep disorders with NE in some children, which is consistent with the report of T. Nevéus [@pone.0099316-Neveus2] that states that NE is not only a nocturnal problem but also a disorder of sleep. The parents of children who wet the bed often claim that their children are "deep sleepers". Children with NE may, however, experience sleep disorders. One recent study of children with NE indicates that the sleep of these children is significantly more fragmented and that these children experience excessive daytime sleepiness [@pone.0099316-CohenZrubavel1]. This sleep fragmentation leads to an increased arousal threshold [@pone.0099316-Roehrs1], [@pone.0099316-Philip1], which, in turn, results in the loss of physiologic inhibitory signals to the bladder that have been observed in animal studies [@pone.0099316-Kiddoo1].

Sleep disorders may play a role in development of NE. Based on this finding, we measured serum 25(OH)D concentrations, effective on sleep patterns, in enuretic children. There is an anatomic evidence for an association between 25(OH)D and sleep patterns, which is supported by the presence of vitamin D receptors in the anterior and posterior hypothalamus, substantia nigra, midbrain central gray, raphe nuclei, and the nuclei reticularis pontis oralis and caudalis [@pone.0099316-Eyles1]. These same areas are thought to play important roles in the initiation and maintenance of sleep. Moreover, clinical studies suggest that vitamin D supplementation for patients with sleep disorders may contribute to significant improvements in sleep quality [@pone.0099316-Gominak1], [@pone.0099316-Huang1]--[@pone.0099316-McCarty1].

Low 25(OH)D is proposed to contribute to immune dysregulation including inducing a relative elevation of circulating IL-1, IL-2, IL-6, TNFα and NFκB, all of which can result in subjective sleepiness symptoms [@pone.0099316-Suzuki1]--[@pone.0099316-Vgontzas1]. Therefore, it is mechanistically plausible that suboptimal concentrations of 25(OH)D may contribute to poor sleep quality by directly modulating immune-regulating substances [@pone.0099316-McCarty2]. Together, these studies confirm the hypothesis that Low 25(OH)D contributes to sleep disorders, which, in turn, lead to an increase in the risk of NE. However, this hypothesis is still under discussion and need to be confirmed by further studies.

Another possible mechanism involves an interaction between vitamin D deficiency and other disorders, particularly OSA. Vitamin D deficiency is correlated with chronic rhinitis [@pone.0099316-Abuzeid1], tonsillar hypertrophy [@pone.0099316-Nunn1]--[@pone.0099316-Reid1], and nonspecific myopathy [@pone.0099316-Glerup1]--[@pone.0099316-Russell1], all of which are known to increase the risk of OSA. Therefore, Low 25(OH)D represents a plausible factor that could lead to more severe OSA.

Sleep research has documented that NE is related to OSA in children [@pone.0099316-Leiberman1]--[@pone.0099316-Beebe1]. Nocturnal polyuria is considered to be a characteristic of OSA [@pone.0099316-Umlauf1]. Patients with OSA excrete large amounts of urine overnight [@pone.0099316-Umlauf1], probably because of increased secretion of atrial natriuretic peptide (ANP), which is released from the heart in response to volume expansion and acts on the kidneys to increase dieresis [@pone.0099316-Brenner1]. The association between these two conditions in children is supported by partly or completely resolution of NE after effective treatment of OSA [@pone.0099316-Umlauf1], [@pone.0099316-Hjalmas1].

Nocturnal polyuria has been considered as an important pathogenic factor of NE. This idea was supported by Butler RJ et al. [@pone.0099316-Butler1]--[@pone.0099316-Butler2], who noted that a proportion of enuretic children had excessive nocturnal urine production. There is evidence indicating that vitamin D directly contributes to the development of polyuria, which is in agreement with the report that mice lacking the vitamin D receptor (i.e., VDR(−/−) mice) develop polyuria, with 24h urinary volume increased several-fold compared with VDR(+/+) mice [@pone.0099316-Li1]. The initial molecular event that leads to the development of polyuria is the upregulation of renin in the kidney and the brain, which is caused by VDR inactivation [@pone.0099316-Kong1]. The molecular basis for renin upregulation is that 1,25-dihydroxyvitamin D suppresses renin gene transcription by blocking the cAMP response element (CRE)-mediated promoter activity [@pone.0099316-Yuan1]. Renin upregulation leads to an increase in the production of AngII, which, in turn, stimulates the central regulation of water intake, leading to polyuria in a context of normal fluid handling by the kidney [@pone.0099316-Kong1].

This study has several limitations that should be noted. First, we did not perform a statistical analysis that differentiated between patients with primary and secondary enuresis (i.e., the absence or presence, respectively, of a dry period for over 6 months), however, the majority of children are expected to have primary enuresis. This study also did not differentiate between monosymptomatic and polysymptomatic enuresis (i.e., the absence or presence, respectively, of lower urinary tract dysfunction). Second, family history of bedwetting has been found to significantly affect the prevalence of NE [@pone.0099316-Gunes1], but was not examined in this study.

Conclusions {#s5}
===========

In conclusion, this study indicates that there is a statistically significant relationship between serum 25(OH)D concentrations and NE in five- to seven-year-old children. The discovery of the association between 25(OH)D and NE opens a new area of research on the role of vitamin D in the regulation of physiological processes. Further research is needed to confirm this association and to explore more detailed mechanism.
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